Prostatic Hypertrophy, Benign Active Not Recruiting Phase 2 Trials for Mirabegron (DB08893)

Also known as: Benign Prostatic Hypertrophy (BPH) / Benign Prostatic Hypertrophy / BPH / Prostatic hypertrophy (benign) / Benign prostatic hyperplasia / Enlarged prostate (benign)

IndicationStatusPhase
DBCOND0029457 (Prostatic Hypertrophy, Benign)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03600766Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized StudyTreatment